Activation of blood coagulation and deposition of insoluble fibrin invariably contribute to the pathogenesis of vascular injury and the athero-thrombotic disease. Recent studies from the investigator's laboratory have demonstrated that through the interaction with specialized membrane receptors, fibrinogen enhances the adhesion of leukocytes to vascular endothelium by acting as a molecular bridge between the two cell types. Mimicking the earliest atherosclerotic lesion of intraintimal leukocyte infiltration, this adhesion step is followed by monocyte and neutrophil migration across the endothelial cell monolayer. Therefore, a direct role of leukocyte-dependent coagulation in the pathogenesis of vascular injury is hypothesized, and will constitute the focus of the present application. In the first Specific Aim, the ability of plasma adhesive proteins and coagulation factors to support leukocyte-endothelium bridging will be investigated under static or physiologic flow conditions, with respect to cell activation requirements and regulatory pathways of receptor-ligand trafficking. The receptor and ligand structural recognition sites implicated in intercellular bridging will be identified in the second Specific Aim by synthetic peptidyl mimicry, receptor-ligand chemical cross-linking, epitope-mapping of functionally blocking monoclonal antibodies, and rationally targeted site-directed receptor mutants. In the third Specific Aim, the mechanism of leukocyte locomotion across the endothelial cell monolayer will be dissected in its potential requirements of inflammatory/chemotactic cytokines, modulation of activation-dependent genes, and local proteolytic activation of coagulation. The long term objective of these studies is to identify highly selective antagonists of leukocyte adhesion reactions that will reduce vascular damage without affecting cellular hemostatic functions.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL043773-09
Application #
2714021
Study Section
Hematology Subcommittee 2 (HEM)
Project Start
1992-07-01
Project End
2000-05-31
Budget Start
1998-06-01
Budget End
1999-05-31
Support Year
9
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Yale University
Department
Pathology
Type
Schools of Medicine
DUNS #
082359691
City
New Haven
State
CT
Country
United States
Zip Code
06520
Craig, A; Fernandez-Reyes, D; Mesri, M et al. (2000) A functional analysis of a natural variant of intercellular adhesion molecule-1 (ICAM-1Kilifi). Hum Mol Genet 9:525-30
Altieri, D C (1999) Regulation of leukocyte-endothelium interaction by fibrinogen. Thromb Haemost 82:781-6
Mesri, M; Altieri, D C (1999) Leukocyte microparticles stimulate endothelial cell cytokine release and tissue factor induction in a JNK1 signaling pathway. J Biol Chem 274:23111-8
Ambrosini, G; Adida, C; Sirugo, G et al. (1998) Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting. J Biol Chem 273:11177-82
Plescia, J; Conte, M S; VanMeter, G et al. (1998) Molecular identification of the cross-reacting epitope on alphaM beta2 integrin I domain recognized by anti-alphaIIb beta3 monoclonal antibody 7E3 and its involvement in leukocyte adherence. J Biol Chem 273:20372-7
Adida, C; Berrebi, D; Peuchmaur, M et al. (1998) Anti-apoptosis gene, survivin, and prognosis of neuroblastoma. Lancet 351:882-3
Papapetropoulos, A; Piccardoni, P; Cirino, G et al. (1998) Hypotension and inflammatory cytokine gene expression triggered by factor Xa-nitric oxide signaling. Proc Natl Acad Sci U S A 95:4738-42
Adida, C; Crotty, P L; McGrath, J et al. (1998) Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation. Am J Pathol 152:43-9
Mesri, M; Plescia, J; Altieri, D C (1998) Dual regulation of ligand binding by CD11b I domain. Inhibition of intercellular adhesion and monocyte procoagulant activity by a factor X-derived peptide. J Biol Chem 273:744-8
Mesri, M; Altieri, D C (1998) Endothelial cell activation by leukocyte microparticles. J Immunol 161:4382-7

Showing the most recent 10 out of 39 publications